ImpactRx Releases Key Data on U.S. Pharmaceutical Promotion Activity; - Keynote Presentation From Joint Conference with Prudential Financial Now Accessible on impactrx.com -.
"It is unique to have a conference that drills down into the analytics in this way," said Dr. Anderson. "In the one-year that Prudential Financial has been utilizing ImpactRx data to augment other sources of data, we have routinely gotten a leg up on our competitors in terms of discerning specific indicating factors beneath the surface of such major events as new drug launches. This conference gave us the opportunity to share this newfound source of intelligence with our clients and articulate how the factors tracked in this data are critical to a product's ultimate commercial success."
The keynote presentation, delivered by ImpactRx Co-Founder Terry Overton, Ph.D., provided an overview of the data ImpactRx captures on the efficiency of the industry's sales forces and a narrative on the nature of personal pharmaceutical promotion in the United States today. Also presenting from ImpactRx were Gerald J. Gallivan, Co-Founder, Chairman and Chief Executive Officer, Robert Caprara, Vice President, Advanced Analytics and Martin Glogowski, Vice President, Market Research. The presentations delivered by these speakers have also been posted to the ImpactRx website (http://www.impactrx.com/) in addition to the keynote presentation.
"We are very encouraged by the high level of interest our data received from the buy-side analysts attending the Prudential conference," said Mr. Gallivan. "To have ImpactRx data utilized -- and recognized in a public forum -- by one of the most respected securities firms in the world is an invaluable endorsement of our capabilities."
ImpactRx comprehensively collects data on promotion and physician treatment decisions for every pharmaceutical product currently marketed in the United States from its exclusive network of high prescribing physicians. Founded in October 2000, ImpactRx's physician network is the source of an unprecedented intelligence capability for tracking the promotional initiatives of the pharmaceutical industry and measuring their effect on prescribing behavior. Based in Mount Laurel, New Jersey, ImpactRx is a private company with investment financing provided by Mediphase Venture Partners (http://www.mediphaseventure.com/) and Oxford Bioscience Partners (http://www.oxbio.com/).
CONTACT: Patrick Angelastro, Vice President, Marketing & Client Services of ImpactRx, Inc., +1-856-273-0221, ext. 102, email@example.com; or Pete Holmberg (Media), +1-917-322-2164, firstname.lastname@example.org, or Melody A. Carey (Investors), +1-917-322-2571, email@example.com, both of Rx Communications Group, LLC, for ImpactRx, Inc.
Web site: http://www.impactrx.com/ http://www.mediphaseventure.com/ http://www.oxbio.com/